Vaccines - Strategic Insights Report (Page 5)

Vaccines

Immunology of Vector-Borne Diseases: The Role of Immunopharmacology in Controlling Viral and Parasitic Infections

Recent study results have been published on Biotechnology - Gene Therapy, revealing crucial insights into understanding the immunopharmacological mechanisms underlying vector-borne diseases. The study, conducted by researchers from the Shiraz University of Medical Sciences, aimed to explore the immunomodulatory effects of vector saliva, pathogen-induced immune evasion, and host-directed immunotherapies to

Vaccines

Digital Public Health Tools: Understanding Barriers to Adoption in a Post-Pandemic World

In the midst of the COVID-19 pandemic, digital public health tools emerged as alternatives to traditional paper records, aiming to limit the spread of disease. The Washington State Department of Health launched 'WA Verify,' a QR code-based vaccine verification system, in November 2021. However, concerns about privacy, surveillance,

Vaccines

COVID-19 Vaccine Hesitancy Persists Among Syrian University Students

A recent study from Saarland University in Germany has highlighted the complex issue of COVID-19 vaccine hesitancy among university students in Syria, a low-resource setting where vaccination remains the primary means of protection against the virus. The study aimed to elucidate the determinants of vaccine hesitancy among medical and non-medical

Vaccines

Advances in mRNA Vaccine Delivery Using Lipid Nanoparticles

Researchers at the University of Lyon 1 have made significant progress in understanding the delivery of messenger RNAs (mRNAs) using lipid nanoparticles (LNPs), which have emerged as a promising vehicle for therapeutic and prophylactic medications. The study, funded by Sanofi-Aventis, sheds light on the role of cationic lipids in the

Vaccines

Human Papillomavirus Vaccines Show Promise in Reducing Infection Rates in Weifang City, China

A recent study published in the Journal of Medical Virology has shed light on the prevalence of human papillomavirus (HPV) infections in Weifang City, China. The research, conducted from 2012 to 2023, collected a total of 81,397 specimens of cervical epithelium and found that the overall infection rate of

Vaccines

SK Bioscience Enters Clinical Trials for Universal Vaccine to Combat COVID-19 and Future Coronavirus Strains

As the world continues to grapple with the COVID-19 pandemic, SK Bioscience is taking a pioneering step towards developing a universal vaccine that can combat various coronavirus strains, including COVID-19 and SARS. The company has submitted a global Phase 1/2 clinical trial plan for its vaccine candidate 'GBP511&

Vaccines

Nanoparticle-Based Antigen Enhances Humoral Immune Responses and Increases Antigenicity

Researchers from Hunan Agricultural University have presented a new study on the use of nanoparticles (NPs) to enhance antigenicity and induce high levels of humoral immune responses. According to the study published in the International Journal of Biological Macromolecules, the team designed three protein-based NPs derived from Ferritin, porcine circovirus

Vaccines

Democratic Governors Form Public Health Alliance to Counter Trump Administration's Guidance

Democratic governors from 15 states and one U.S. territory have come together to form a public health alliance that diverges from guidance provided by the Trump administration and U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The alliance aims to strengthen collaboration among states in emergency

Vaccines

Intestinal Inflammation Induced by Heat-Labile Toxin-Producing Enterotoxigenic E: Coli Infection

Enterotoxigenic Escherichia coli (ETEC) causes significant morbidity, mortality, and growth faltering among children, particularly in low- and middle-income countries. While gut inflammation contributes to growth faltering, the role of ETEC in inflammation remains poorly understood. Researchers at Johns Hopkins University Bloomberg School of Public Health evaluated the intestinal inflammation induced

Vaccines

mRNA Vaccine-Based Cancer Immunotherapy Shows Promise with Engineered Splenic Vaccine

Researchers at the First Affiliated Hospital of Zhengzhou University have engineered a spleen-selective mRNA-LNPs vaccine that reduces inflammation while maintaining cellular immunity, offering a promising strategy for cancer immunotherapy. This innovative design principle may redefine the development of mRNA vaccines for cancer treatment. The engineered vaccine achieved superior mRNA translation

Vaccines

Harnessing Artificial Intelligence for Zero-Dose Children: A Step Towards Global Health Equity

Researchers have identified a crucial role for artificial intelligence in addressing the challenge of zero-dose children, particularly in low- and middle-income countries where vulnerable children have limited access to immunizations. The study highlights how AI can enhance routine childhood immunization by identifying zero-dose populations, optimizing vaccine delivery, and supporting data-driven

Kennedy, Robert F., Jr.

Aluminum in Vaccines: A Review of Safety and Effectiveness

President Trump's recent comments about removing aluminum from childhood vaccines have sparked concern among vaccine experts and health officials. Aluminum salts have been used in vaccines since the 1920s to enhance the immune-stimulating effect against viruses or bacteria. However, a recent call for removal has set off alarms,

See all